Elsevier

Biochemical Pharmacology

Volume 86, Issue 2, 15 July 2013, Pages 200-209
Biochemical Pharmacology

Commentary
Role of AMPK activation in oxidative cell damage: Implications for alcohol-induced liver disease

https://doi.org/10.1016/j.bcp.2013.05.007Get rights and content

Abstract

Chronic alcohol consumption is a well-known risk factor for liver disease. Progression of alcohol-induced liver disease (ALD) is a multifactorial process that involves a number of genetic, nutritional and environmental factors. Experimental and clinical studies increasingly show that oxidative damage induced by ethanol contributes in many ways to the pathogenesis of alcohol hepatoxicity. Oxidative stress appears to activate AMP-activated protein kinase (AMPK) signaling system, which has emerged in recent years as a kinase that controls the redox-state and mitochondrial function. This review focuses on the most recent insights concerning the activation of AMPK by reactive oxygen species (ROS), and describes recent evidences supporting the hypothesis that AMPK signaling pathways play an important role in promoting cell viability under conditions of oxidative stress, such as during alcohol exposure. We suggest that AMPK activation by ROS can promote cell survival by inducing autophagy, mitochondrial biogenesis and expression of genes involved in antioxidant defense. Hence, increased intracellular concentrations of ROS may represent a general mechanism for enhancement of AMPK-mediated cellular adaptation, including maintenance of redox homeostasis. On the other hand, AMPK inhibition in the liver by ethanol appears to play a key role in the development of steatosis induced by chronic alcohol consumption. Although more studies are needed to assess the functions of AMPK during oxidative stress, AMPK may be a possible therapeutic target in the particular case of alcohol-induced liver disease.

Introduction

Chronic alcohol consumption is a well-known risk factor for liver disease, which represents a major cause of morbidity and mortality worldwide [1]. Progression of alcohol-induced liver disease (ALD) is a multifactorial process that involves a number of genetic, nutritional and environmental factors [2]. Among the mechanisms implicated in the pathogenesis of ALD, oxidative stress has received growing interest [3]. Oxidative stress exists when there is an imbalance between oxidants and antioxidant defenses in favor of the oxidants in the cell. Reactive oxygen species (ROS) are produced by normal cellular metabolism with beneficial effects such as cytotoxicity against bacteria and other pathogens. However, these reactive species also may affect cells of the host organism, by leading to the oxidation of cellular macro-molecules, such as lipids, protein or DNA, inhibiting normal function [4]. For instance, peroxidation of lipids can result in destruction of biological membranes [5], while alterations induced by ROS in different signaling pathways may modulate gene expression, cell metabolism, cell cycle and cell death [5], [6].

Oxidative stress appears to activate the AMP-activated protein kinase (AMPK) signaling system in various cell types, including neuronal, heart, skeletal and vascular smooth muscle, pancreatic and liver cells [7]. AMPK plays a key role in cellular and organism survival during metabolic stress by its ability to maintain metabolic homeostasis. However, it also controls the redox-state and mitochondrial function. Interestingly, AMPK-associated pathways may suppress the cell death induced by oxidative stress [8]. For example, AMPK seems to be required for ROS-triggered autophagy, which promotes cell survival in response to cellular stresses, such as nutrient starvation, hypoxia or ischemia [9].

The first part of this review focuses on the most recent insights concerning the activation of AMPK by oxidative stress. We then describe recent evidence supporting the hypothesis that AMPK signaling pathways play an important role in promoting cell viability under conditions of oxidative stress, such as during alcohol exposure.

Section snippets

Involvement of oxidative stress and AMPK in ALD

Steatosis induced by chronic alcohol consumption can be directly linked to a critical signaling pathway that increases lipogenesis in the liver, i.e., AMPK inhibition [10]. Indeed, AMPK activates fatty acid oxidation and inhibits lipogenesis in rat hepatocytes and in the livers of ethanol-fed mice [11]. The inhibition of AMPK leads to activation of acetyl-CoA carboxylase (ACC), enhancing malonyl CoA levels, which inhibit fatty acid uptake and β-oxidation in mitochondria. However, chronic

AMPK regulates cell death induced by ROS

A decade ago, many studies have shown that AMPK played an important role in the decision between cell survival and death [56]. Early reports showed that pharmacological activation of AMPK protected fibroblast from apoptosis induced by serum withdrawal [57]. AMPK was also shown to play a critical role in protecting the liver from ischemia-reperfusion injury [58]. Based on experiments with AMPK activators and inhibitors, Saberi et al. [59] showed that the upregulation of AMPK promoted hepatocyte

Involvement of AMPK–autophagy axis in ALD

Several direct and indirect arguments suggest that alcohol consumption suppresses liver cell autophagy. First, rats chronically fed with ethanol have a reduced number of autophagic vacuoles in liver cells [107]. Second, chronic ethanol consumption slows down the catabolism of long-lived proteins in the rat liver [108]. Moreover, hepatocytes from patients with alcoholic steatohepatitis contain protein aggregates called Mallory-Denk bodies (MDBs). These Mallory-Denk bodies, the major constituents

Conclusion and future perspectives

Although AMPK has been studied for more than three decades, many questions remain regarding its function, regulation and downstream targets. Depending on the model used, the type of stress applied and the experimental conditions, AMPK may have different roles.

AMPK activation by ROS can promote cell survival by inducing autophagy, mitochondrial biogenesis and expression of genes involved in antioxidant defense. Hence, increased intracellular concentrations of ROS may represent a general

Acknowledgments

This work was supported by grants from Wallonie (Biowin). Julien Verrax is a Belgian Fonds National de la Recherche Scientifique (FNRS) postdoctoral researcher.

References (115)

  • L. Chen et al.

    Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells

    Lab Invest

    (2010)
  • Y. Cai et al.

    Increased oxygen radical formation and mitochondrial dysfunction mediate beta cell apoptosis under conditions of AMP-activated protein kinase stimulation

    Free Radic Biol Med

    (2007)
  • A. Woods et al.

    LKB1 is the upstream kinase in the AMP-activated protein kinase cascade

    Curr Biol

    (2003)
  • Z. Xie et al.

    Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells

    J Biol Chem

    (2006)
  • A. Barzilai et al.

    ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage

    DNA Repair (Amst)

    (2002)
  • A. Woods et al.

    Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells

    Cell Metab

    (2005)
  • O. Göransson et al.

    Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase

    J Biol Chem

    (2007)
  • J.W. Zmijewski et al.

    Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase

    J Biol Chem

    (2010)
  • P. Song et al.

    Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems

    Free Radic Biol Med

    (2012)
  • P. Durante et al.

    Apoptosis induced by growth factor withdrawal in fibroblasts overproducing fructose 2,6-bisphosphate

    FEBS Lett

    (1999)
  • C. Peralta et al.

    Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat

    Hepatology

    (2001)
  • Y. Wang et al.

    Involvement of oxygen-regulated protein 150 in AMP-activated protein kinase-mediated alleviation of lipid-induced endoplasmic reticulum stress

    J Biol Chem

    (2011)
  • J. Xi et al.

    Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore

    Eur J Pharmacol

    (2009)
  • S.B. Wu et al.

    AMPK-mediated increase of glycolysis as an adaptive response to oxidative stress in human cells: implication of the cell survival in mitochondrial diseases

    Biochim Biophys Acta

    (2012)
  • D. Schubert

    Glucose metabolism and Alzheimer's disease

    Ageing Res Rev

    (2005)
  • D. Meisse et al.

    Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells

    FEBS Lett

    (2002)
  • R. Rattan et al.

    5-Aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase

    J Biol Chem

    (2005)
  • Y. Zhao et al.

    Glucose metabolism attenuates p53 and Puma-dependent cell death upon growth factor deprivation

    J Biol Chem

    (2008)
  • N.L. Alves et al.

    The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells

    Immunity

    (2006)
  • W.B. Zhang et al.

    Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition

    J Biol Chem

    (2010)
  • P.E. Rautou et al.

    Autophagy in liver diseases

    J Hepatol

    (2010)
  • F. Cecconi et al.

    The role of autophagy in mammalian development: cell makeover rather than cell death

    Dev Cell

    (2008)
  • J. Hemelaar et al.

    A single protease, Apg4B, is specific for the autophagy-related ubiquitin-like proteins GATE-16, MAP1-LC3, GABARAP, and Apg8L

    J Biol Chem

    (2003)
  • R. Scherz-Shouval et al.

    ROS, mitochondria and the regulation of autophagy

    Trends Cell Biol

    (2007)
  • G.R. De Meyer et al.

    Autophagy in the cardiovascular system

    Biochim Biophys Acta

    (2009)
  • S. Pattingre et al.

    Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy

    Cell

    (2005)
  • D. Meley et al.

    AMP-activated protein kinase and the regulation of autophagic proteolysis

    J Biol Chem

    (2006)
  • D. Deeb et al.

    Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism

    Biochem Pharmacol

    (2010)
  • J.M. Eom et al.

    Alpha-eleostearic acid induces autophagy-dependent cell death through targeting AKT/mTOR and ERK1/2 signal together with the generation of reactive oxygen species

    Biochem Biophys Res Commun

    (2010)
  • K.G. Ishak et al.

    Alcoholic liver disease: pathologic, pathogenetic and clinical aspects

    Alcohol Clin Exp Res

    (1991)
  • C.P. Day

    Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease

    Liver Int

    (2006)
  • J.I. Cohen et al.

    Redox signaling and the innate immune system in alcoholic liver disease

    Antioxid Redox Signal

    (2011)
  • H. Nakazawa et al.

    Pathological aspects of active oxygens/free radicals

    Jpn J Physiol

    (1996 Feb)
  • M. Tien Kuo et al.

    Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers

    Mol Carcinog

    (2006)
  • Q. Huang et al.

    A novel function of poly(ADP-ribose) polymerase-1 in modulation of autophagy and necrosis under oxidative stress

    Cell Death Differ

    (2009)
  • M. Hu et al.

    Regulation of hepatic lipin-1 by ethanol: role of AMP-activated protein kinase/sterol regulatory element-binding protein 1 signaling in mice

    Hepatology

    (2012)
  • K. Tomita et al.

    AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats

    Alcohol Clin Exp Res

    (2005)
  • M. You et al.

    Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice

    Hepatology

    (2005)
  • Z. Shen et al.

    Involvement of adiponectin–SIRT1–AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice

    Am J Physiol Gastrointest Liver Physiol

    (2010)
  • H. Everitt et al.

    Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice

    Am J Physiol Gastrointest Liver Physiol

    (2013)
  • Cited by (125)

    • Antioxidant effects of Se-glutathione peroxidase in alcoholic liver disease

      2022, Journal of Trace Elements in Medicine and Biology
    View all citing articles on Scopus
    View full text